Key Takeaways For Dental Practice Owners
- Dental practices typically sell for 60% to 85% of annual collections, with most falling in the 65% to 85% range depending on profitability and owner dependence.
- Revenue multiples act as screening tools built from buyer financing assumptions and shift with interest rates and market conditions.
- Key value drivers can include payer mix, hygiene production percentage, active patient count, overhead control, and reduced owner dependence.
- Revenue multiples work best when tested against implied EBITDA multiples to see whether they are realistic and defensible during buyer diligence.
- McLerran & Associates provides CPA-led, diligence-grade valuations that estimate a practice’s worth across both private-buyer and DSO markets.
Get a diligence-grade valuation before you accept a quoted multiple.
How A Revenue Multiple Is Calculated And Why It Is Only A Starting Point
A revenue multiple expresses the percentage of collections a buyer believes can service acquisition debt and still meet a target return. It works as a quick screening tool rather than a full dental practice valuation formula.
The arithmetic is straightforward. If a practice collects $1 million annually and a buyer offers 0.75x collections, the offer is $750,000. That number usually comes from the buyer’s financing assumptions, cost of capital, and target return, instead of the practice’s detailed profitability. Analyses note that price differences between buyer types often reflect differences in financing capacity and valuation methods rather than an arbitrary willingness to pay more or less.
The revenue multiple tends to move with interest rates and buyer financing conditions. Industry reports attribute the compression in large DSO valuation multiples down from historical peaks to higher cost of capital and persistent inflation. Financial structures are recalibrating around a more expensive borrowing environment.
Sophisticated buyers and DSOs use the revenue multiple as a first filter. After they look under the hood, they shift to adjusted EBITDA, which means earnings before interest, taxes, depreciation, and amortization, normalized to reflect what the practice would earn under new ownership. Guides explain that a collections-based indication implying an unusually high EBITDA multiple often triggers questions about provider replacement cost, hygiene staffing, rent, lab expense, payer adjustments, and production sustainability. The revenue multiple starts the conversation. EBITDA usually guides the final number. McLerran & Associates’ EBITDA valuation resources explore this topic in more detail.
Worked Example: What A Multiple Of Revenue Means In Dollars
At a 0.6x to 0.9x range, a practice collecting $1 million would see proceeds before debt, taxes, and deal structure of roughly $600,000 to $900,000. The table below shows how the dollar gap between the low and high end widens as collections grow. At $2 million in collections, the difference between a 0.60x and 0.90x multiple is $600,000.
| Annual Collections | At 0.60x (Low End) | At 0.75x (Midpoint) | At 0.90x (High End) |
|---|---|---|---|
| $1,000,000 | $600,000 | $750,000 | $900,000 |
| $1,500,000 | $900,000 | $1,125,000 | $1,350,000 |
| $2,000,000 | $1,200,000 | $1,500,000 | $1,800,000 |
This illustration shows pure arithmetic. It does not promise a specific outcome. Actual proceeds depend on the practice’s profitability, payer mix, deal structure, debt obligations, and tax treatment.
Guides often describe the full proceeds bridge in several steps. First, normalized EBITDA multiplied by the selected multiple equals enterprise value. Then subtract net debt and adjust for working capital. Finally, subtract escrow, earnouts, rollover equity, and holdbacks to estimate cash at close. The revenue multiple represents only the first step in that chain.
The dollar gap between the low end and the high end at $2 million in collections is $600,000. That gap usually reflects the practice characteristics described above. A diligence-grade valuation is designed to measure and defend that difference.
Revenue Multiple Vs. EBITDA Multiple: When Each One Applies
The revenue multiple usually serves as owner-facing shorthand in doctor-to-doctor deals and early screening, while the EBITDA multiple tends to guide DSO and private-equity buyers after diligence. Knowing which metric applies at each stage can help an owner interpret dental practice valuation multiples more clearly.
In doctor-to-doctor transactions, individual buyers using SBA loans often anchor on seller’s discretionary earnings (SDE). SDE means net profit plus the owner’s compensation and discretionary add-backs. These buyers are constrained by what lenders will finance. Industry reports place private buyer SDE multiples at 1.75x to 2.25x in 2026.
In DSO and private-equity transactions, buyers calculate adjusted EBITDA by replacing the owner-dentist’s full compensation with a market-rate associate salary. A corporate buyer must pay someone to sit in the operatory after the seller leaves. Guides note that a practice might show $400,000 in SDE but only $200,000 in normalized EBITDA. That gap represents the value of the owner’s own labor and can be one of the most common sources of confusion in dental valuations.
On the topic of EBITDA multiples, the market often shows a range driven by practice scale, specialty, payer mix, and buyer type. Reports place current dental practice valuations at roughly 5x to 9x EBITDA, with expectations of some compression toward more conservative ranges over the next few years. Industry notes indicate that smaller practices have seen multiples adjust back toward traditional 5x to 6x ranges. Larger, associate-led, multi-location groups can reach higher multiples when institutional acquirers compete in a structured process.
See how your practice is valued in both the private-buyer and DSO markets.
How To Sanity-Check A Quoted Multiple Of Revenue
Practice owners can run a quick reality check on a quoted multiple by pulling five numbers from their own P&L and patient data. Each input signals something specific to a buyer and can move the multiple up or down.
- Collections and the three-year average. Buyers want to see a stable or growing trend, which is why they look at the three-year average rather than only the most recent year. A single strong year that follows two flat ones often gets underwritten conservatively. Three years of consistent growth can support the top of the range.
- Overhead as a percentage of collections. Guides identify profitability as one of the main drivers of sale value. They note that a practice controlling overhead at 55% is worth meaningfully more than an identical-collections practice running 72% overhead, even though both would receive the same dollar figure under a simple revenue-multiple calculation.
- Payer mix. Guides identify payer mix as one of the largest drivers of dental practice multiples. They note that 60% or more fee-for-service revenue can be worth several full multiple turns more than equivalent Medicaid or HMO earnings. A practice with more than 30% Medicaid typically sees a 0.5x to 1.0x discount on its multiple.
- Hygiene production as a percentage of collections. Buyers often target 25% to 35% of total practice production from hygiene. Below that threshold, buyers may price in a patient retention concern. Above it, hygiene can signal recurring, provider-independent revenue that continues after the selling dentist exits.
- Active patient count. Buyers usually look at patients seen in the last 18 months. A count trending upward can support the top of the range. A declining count signals attrition that buyers tend to price in.
After gathering those five numbers, owners can compare the quoted revenue multiple against what their overhead and payer mix would support. Guides describe a simple check. Sophisticated buyers calculate implied value both ways, starting with a collections percentage and then translating it into an implied EBITDA multiple to see whether that multiple looks supportable. If the quoted multiple implies an EBITDA multiple that conflicts with the practice’s overhead and payer mix, the number often fails in diligence.
That risk explains why many owners bring in a dental-only sell-side advisor before going to market. McLerran & Associates, for example, has evaluated more than 10,000 practices and builds a CPA-led, diligence-grade EBITDA analysis and valuation that unpacks every add-back, shapes the narrative around profitability, and produces a number that tends to hold up when buyers scrutinize it instead of getting re-traded mid-process. McLerran represents the owner, never the buyer, and works both the private-buyer and DSO paths in roughly equal measure so the valuation reflects what the practice may be worth in both markets.
Rules Of Thumb Vs. Real Valuation For Dental Practices
Common dentistry “rules” shared in study clubs and online forums work as heuristics rather than full valuations. No single multiple can serve as a complete valuation. Guides state that a dental practice valuation rule of thumb usually assumes similar margins, provider replacement costs, patient retention, equipment needs, payer realization, and transition risk across practices, even though those assumptions rarely match reality.
Industry reports highlight this structural weakness. A $1 million-collection practice with 60% overhead clears $400,000 in operating profit, while one with 75% overhead clears only $250,000. Yet both would receive the same $750,000 valuation at a 75% revenue multiplier. The rule of thumb cannot distinguish between them. A diligence-grade valuation can.
Frequently Asked Questions
What Is The Average Multiple Of Revenue For A Dental Practice?
Most general dental practices in private (non-DSO) sales trade in a range of roughly 65% to 85% of annual gross collections, with some sources extending the low end to about 60%. As noted earlier, most private sales fall in the 60% to 85% range, and the midpoint is often cited around 70% to 85% of annual collections per the Goodwill Registry / Henry Schein DPT (2025). The range is wide because practice quality varies significantly. A fee-for-service practice with strong hygiene production, a growing active patient base, and low owner dependence can sit toward the top of that range. A Medicaid-heavy practice where the selling dentist personally produces most of the revenue can sit at or below the bottom. These differences explain why a professional valuation can be helpful for any owner within 2 to 3 years of a transition decision.
Is 70% Of Collections A Normal Sale Price For A Dental Practice?
Seventy percent of collections sits within the range that multiple industry sources cite for general dental practices in private doctor-to-doctor sales, so it appears frequently in real transactions. Whether it fits a specific practice depends on that practice’s profitability, payer mix, hygiene production, active patient count, and owner dependence. A practice with strong fundamentals may be undervalued at 70% of collections. A practice with high overhead and heavy Medicaid exposure may be fairly valued or even generously valued at that figure. The percentage of collections works as a starting point for a conversation rather than a final conclusion.
Why Did One Practice Sell For 1x Collections And Another For 0.6x?
The gap usually reflects differences in the underlying economics. A practice that sold near or above 1x collections likely had associate-driven production, a fee-for-service or PPO-dominant payer mix, strong hygiene utilization, a growing active patient base, and multiple competing buyers, including DSO or private-equity buyers using EBITDA-based underwriting. Those buyers can sometimes pay more than individual dentists using SBA loans. A practice that sold at 0.6x likely showed the opposite profile, such as high owner dependence, elevated overhead, Medicaid concentration, or a thin buyer pool. The multiple tends to be an output of those fundamentals.
What Multiple Of EBITDA Do Dental Practices Sell For?
EBITDA multiples for dental practices can vary by practice scale, buyer type, specialty, and market conditions. Smaller, owner-dependent single-location practices often attract lower multiples from individual buyers or small DSO tuck-in buyers. Larger, associate-led, multi-location groups with strong EBITDA can attract higher multiples from regional and institutional buyers competing in a structured process. Specialty practices can sometimes command premiums over general dentistry at comparable scale. The current rate environment has compressed multiples from post-COVID peaks, particularly at the larger end of the market. Any specific multiple quoted to an owner benefits from a test against the practice’s normalized EBITDA rather than only the revenue figure.
How Do I Know If The Multiple I Was Quoted Is Fair?
Owners can evaluate a quoted multiple by translating it into an implied EBITDA multiple and checking whether that multiple aligns with the practice’s overhead, payer mix, hygiene production, and owner dependence. If a buyer quotes 80% of collections while overhead runs 72%, the implied EBITDA multiple may be very high and may face challenges in diligence. If overhead is well controlled and payer mix is fee-for-service dominant, 80% of collections may understate the practice’s value. A dental-specific, CPA-led valuation that works through both the revenue and EBITDA bases can provide a clearer view of whether a quoted number appears realistic and can support stronger negotiation.
Conclusion: Verify The Number Before You Accept It
A quoted multiple of revenue serves as a starting point rather than a full valuation. The drivers behind it, such as payer mix, overhead, hygiene production, active patient count, and owner dependence, can be measured, and a diligence-grade valuation helps an owner verify a quoted number before relying on it.
The information gap between a practice owner who sells once in a career and a buyer who negotiates every week can be significant. A back-of-the-napkin revenue multiple, accepted without scrutiny, often becomes the anchor that determines what an owner walks away with. A CPA-led, diligence-grade EBITDA analysis completed before the deal goes out can shape the narrative around profitability and produce a number that tends to hold up when buyers look closely.
McLerran & Associates is a dental-only sell-side advisor and advocate that has evaluated more than 10,000 practices and closed roughly 2,000 successful transactions representing approximately $2 billion in volume. The firm works both the private-buyer and DSO paths in roughly equal measure, which allows it to deliver a side-by-side valuation estimating a practice’s worth in both markets. This approach helps an owner choose a path with fuller information and negotiate from a more informed position when responding to buyer offers.
Verify your number with a CPA-led valuation.
